Skip to content

Phase 1 study in Staphylococcus aureus endocarditis

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505413-25-00
Acronym
PP-SA-002
Enrollment
12
Registered
2023-10-03
Start date
2024-04-10
Completion date
2025-04-01
Last updated
2025-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious S. aureus endocarditis

Interventions

None listed

Sponsors

Phaxiam Therapeutics
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026